Key result
Avoidance of anticholinesterase agents significantly prolonged extubation time (22.3 vs 14.7 minutes, p=0.01) but resulted in more stable hemodynamics during extubation in post-cardiac surgery patients.
Why the study?
Neostigmine is commonly used for routine neuromuscular reversal but has serious side effects, leading authors to assess if TOF-guided physiological recovery without reversal agents improves the recovery profile.
Does avoiding pharmacological neuromuscular reversal agents improve hemodynamic stability and recovery profile compared to neostigmine/glycopyrrolate in post-cardiac surgery patients?
Observational (n=60)
No
Does avoiding pharmacological neuromuscular reversal agents improve hemodynamic stability and recovery profile compared to neostigmine/glycopyrrolate in post-cardiac surgery patients?
Absolute Event Rate: 22.3% vs 14.7%
p-value: p=0.01
Avoiding anticholinesterase reversal agents and relying on objective neuromuscular monitoring for physiological reversal in post-cardiac surgery patients leads to more stable hemodynamics, despite a slightly longer extubation time.
Avoiding reversal agents was associated with hemodynamic stability despite longer extubation; leaves open whether this warrants randomized trials post-cardiac surgery.
Pretext: Routine reversal of non depolarizing muscle relaxant neuromuscular blockade is common in practice after general anaesthesia. Neostigmine is most commonly used anticholinesterase agent and it has some serious side effects. We designed observational study to assess if avoidance of pharmacological neuro muscular reversal agents in post cardiac surgery patients with acceleromyographic neuromuscular monitoring (TOF) guided physiological reversal of neuromuscular block can have better recovery profile. Methods and Material: 60 patients who were posted for elective cardiac surgery were divided into two groups (Group S: study group and Group C: control group) of 30 patients each. All patients were managed with institutional protocol peri-opertively, except in recovery period at the time when TOF ratio was more than 0.4, group C patients were given fix dose neostigmine/ glycopyrrolate intravenously while Group S patients were given placebo. All patients were extubated when alertness and TOF ratio of 0.9 achieved. Recovery profile of two groups was compared, using standard statistical analysis by paired t test, annova test and Fisher exact test. Results: Extubation time were significantly longer in group S than group C. (Gr.S 22.3 12.4 min, Gr. C 14.7 9.6 min). Patients of group S remained more stable haemodynamically during extubation than group C (p value 0.039). Group C patients had more but statistically non significant new onset arrhythmias post extubation. Other adverse events like nausea, vomiting and respiratory distress were similar in both the groups. None of the patients from any of the group required reintubation. Lengths of stay in recovery as well as length of stay in hospital was not different between the groups. Conclusions: We concluded that with the guidance of objective neuromuscular monitoring we can physiologically reverse neuro muscular blockade and extubate patients without giving anticholinestersase drugs to group of patients with more stable hemodynamics and avoid possible adverse effect of reversal drugs.
No takes yet. Share an insight, caveat, or question.
Dr Gaurav Goyal (2018) conducted an observational in Post cardiac surgery (n=60). Avoidance of anticholinesterase agents (Placebo) vs. Neostigmine 2.5 mg with glycopyrrolate 0.04 mg was evaluated on Extubation time from reversal (p=0.01). Avoidance of anticholinesterase agents significantly prolonged extubation time (22.3 vs 14.7 minutes, p=0.01) but resulted in more stable hemodynamics during extubation in post-cardiac surgery patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: